CAM
DVAX

Cresset Asset Management’s Dynavax Technologies DVAX Stock Holding History

Cresset Asset Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-160,407
Closed -$2.08M – 1528
2025
Q1 		$2.08M Sell
160,407
-15,151
-9% -$200K 0.01% 530
2024
Q4 		$2.24M Buy
175,558
+8,539
+5% +$103K 0.01% 520
2024
Q3 		$1.86M Buy
167,019
+13,558
+9% +$149K 0.01% 850
2024
Q2 		$1.72M Buy
153,461
+13,723
+10% +$160K 0.01% 790
2024
Q1 		$1.73M Buy
139,738
+18,241
+15% +$238K 0.01% 716
2023
Q4 		$1.7M Buy
121,497
+15,629
+15% +$217K 0.01% 661
2023
Q3 		$1.56M Buy
105,868
+9,304
+10% +$131K 0.01% 654
2023
Q2 		$1.25M Buy
+96,564
New +$1.1M ﹤0.01% 832

Other funds holding DVAX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Cresset Asset Management's DVAX Position: Q2 2025 in Review

Cresset Asset Management sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 160,407 shares — an estimated $2.08M sold.

Cresset Asset Management first reported a position in DVAX in Q2 2023 and held it in 8 quarters. The position peaked at $2.24M in Q4 2024. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • Cresset Asset Management reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • Cresset Asset Management sold 160,407 Dynavax Technologies shares in Q2 2025, an estimated $2.08M.
  • Cresset Asset Management first reported a position in Dynavax Technologies in Q2 2023 and held it in 8 quarters.
  • Cresset Asset Management's Dynavax Technologies position peaked at $2.24M in Q4 2024.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Cresset Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.